The success of this work could also provide an important foundation for a cellular model to investigate the pathogenesis of PD when patient skin fibroblasts are reprogrammed into iDPs with Brn2, Sox2 and Foxa2 in vitro. This evidence concerns the gene SOX2 and Parkinson disease.